Zim Laboratories Ltd

BSE: 541400

22

total announcements

541400.BO · 15 min delayed

AnnouncementsDiscussion
BSEBoard MeetingResults1d ago

Zim Laboratories Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, 04th November, 2026 have inter-alia, considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2026.

Zim Laboratories Ltd has announced its unaudited financial results for the quarter and half year ended 30th September 2026, with revenue from operations at Rs. 0.544.56 lakhs and total income at Rs. 0.774.81 lakhs.

Read more →📎 1 attachment
BSEBoard MeetingResults28 Oct 2026

Zim Laboratories Ltd

Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th September, 2026.

Zim Laboratories Ltd has scheduled a Board Meeting on 04/11/2026 to consider and approve the Unaudited Financial Results for the quarter ended 30th September, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveRegulatory16 Oct 2026

Zim Laboratories Ltd

Please find enclosed the Press Release relating to grant of GMP Certification of Compliance by Australia''s TGA to the Company for its manufacturing facility.

Zim Laboratories Ltd has received a Certificate of Good Manufacturing Practice (GMP) Compliance from Australia's Therapeutic Goods Administration (TGA) for its manufacturing facility at B-21/22, MIDC Area, Kalmeshwar, Nagpur, Maharashtra. The certification covers the manufacture of non-sterile finished products across both registered and listed therapeutic goods categories.

Read more →📎 1 attachment
BSECompany UpdateExpansion15 Sept 2026

Zim Laboratories Ltd

Update on completion of investment in the share capitalof ZIM Scientific Office L.L.C. (Step Down Subsidiary) by ZIM Laboratories Limited FZE, wholly owned subsidiary

Zim Laboratories Ltd has completed the investment in the share capital of its step-down subsidiary, ZIM Scientific Office LLC, as per the approved amount. The shareholding of the wholly-owned subsidiary, ZIM Laboratories Limited FZE, remains at 100%.

Read more →📎 1 attachment
BSECompany UpdateResults12 Aug 2026

Zim Laboratories Ltd

Transcript of Q1 FY27 Earning Conference call

Zim Laboratories Ltd has announced its Q1 FY27 earnings conference call transcript, highlighting its EU-GMP remediation process, revenue growth, and EBITDA margins. The company has completed the EU-GMP reinspection and is awaiting the final inspection report, with a comprehensive CAPA plan in place. The company remains confident in its ability to successfully complete the remediation process and unlock growth opportunities.

Read more →📎 1 attachment
BSEAGM/EGMMgmt Change12 Aug 2026

Zim Laboratories Ltd

Please find enclosed the Outcome of Postal Ballot .

Zim Laboratories Ltd has announced the outcome of its postal ballot, where two special resolutions were passed with a requisite majority. The resolutions relate to the revision in remuneration structure and payment of remuneration to Dr. Anwar Daud, Managing Director, and Mr. Zulfiquar Kamal, Whole-Time Director.

Read more →📎 1 attachment
BSECompany UpdateResults6 Aug 2026

Zim Laboratories Ltd

Please find enclosed the disclosure under Regulation 30 of SEBI LODR Regulations regarding Earnings Presentation for Q1 FY 27

Zim Laboratories Ltd has released its Q1 FY27 earnings presentation, showing a 31.2% increase in total operating income to ₹942 Mn and a 40.0% decline in EBITDA to ₹34 Mn. The company's EBITDA margin decreased by 430 bps to 3.7%. R&D spend increased to ₹82 Mn, with ₹34 Mn allocated towards BE studies and regulatory filings. The company has made progress on its EU-GMP CAPA remediation plan, with most of the plan completed and implemented.

Read more →📎 1 attachment
Page 1 of 2Next →